Skip to content
10-K

Annual Report

NUNZIA PHARMACEUTICAL COMPANY

0001683168-22-002707

← back to feed
Filed
Apr 15, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Apr 11, 2022 434.12M sh
Operating Cash Flow FY 2021 · Dec 31, 2021 −$86.78K
Long Term Debt FY 2021 · Dec 31, 2021 $0
Long Term Debt FY 2021 · Dec 31, 2020 $23K
Cash And Equivalents FY 2021 · Dec 31, 2021 $131
Cash And Equivalents FY 2021 · Dec 31, 2020 $0
Stockholders Equity FY 2021 · Dec 31, 2021 −$94.17K
Current Liabilities FY 2021 · Dec 31, 2021 $99.31K
Total Liabilities FY 2021 · Dec 31, 2021 $99.31K
Current Assets FY 2021 · Dec 31, 2021 $131
Total Assets FY 2021 · Dec 31, 2021 $5.13K
Eps Basic FY 2021 · Dec 31, 2021 −$0.26
Sga Expense FY 2021 · Dec 31, 2021 $37.76M
Net Income FY 2021 · Dec 31, 2021 −$78.06M
Operating Income FY 2021 · Dec 31, 2021 −$78.06M
Revenue FY 2021 · Dec 31, 2021 $0